CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Bristol-Myers Squibb Company v. Cipla USA, Inc.

1:16-cv-00074

Overview

Case Number 1:16-cv-00074
Filing Date 2016-02-11
Status Terminated
Termination Date 2016-08-05
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Cipla Limited NPE (University / Research)

Represented By

1 Attorneys Listed

Mary Matterer

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

Cipla USA, Inc. Operating Company

Represented By

3 Attorneys Listed

Mary Matterer

ADDRESS EXPIRED / UNKNOWN

Tel: +1 (302) 888-6800
Fax: +1 (302) 571-1750

ADDRESS EXPIRED / UNKNOWN, (302) 888-6800

Joshua H. Lee

Email: jlee@kilpatricktownsend.com

Anil H. Patel

Email: anil.patel@klgates.com

Bristol-Myers Squibb Company NPE (Individual / Inventor)

Represented By

6 Attorneys Listed

Tracey C. Allen

UNDELIVERABLE EMAIL 6/16/2021

Richard A. Crudo

Email: richard.crudo@wilmerhale.com

Amy K. Wigmore

Email: amy.wigmore@wilmerhale.com

Michael J. Farnan

Farnan LLP

Tel: +1 (302) 777-0338
Fax: +1 (302) 421-5870

919 North Market Street, 12th Floor

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

Joseph J. Farnan , Jr.

Farnan LLP

Tel: +1 (302) 777-0300

919 North Market Street, 12th Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 2 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 2 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (2): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (2 found):
U.S. Courts: 2
U.S. District Court 2015-03-19
1:15-cv-00049

Bristol-Myers Squibb Company v. Mylan Pharmaceuticals, Inc.

Asserted Patent
Status: WVND
U.S. District Court 2010-04-01
1:10-cv-00264

Bristol-Myers Squibb Company v. Teva Pharmaceuticals USA Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6087383
Bisulfate salt of HIV protease inhibitor
Filed: 1998-12-21
Issued: 2000-07-11
Expired (Term Ended)
Expires: 2018-12-21

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

3

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Claim Construction / Markman Filing 1 Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to serve Rule 26 Disclosures, file Protective Order, and to serve Paragraph 4 Disclosures to August 2, 2016 - filed by Bristol-Myers ...
Entry #20 • 2016-07-25 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to (i) Serve Rule 26(a)(1) Initial Disclosures; (ii) Submit Proposed Protective Order; and (iii) Identify Accused Products and make c...
Entry #19 • 2016-07-11 Document →
Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Discovery due by 5/30/2017. Status Report due by 1/5/2017. Claim Const...
Entry #17 • 2016-06-09 Document →

Docket Entries

(22 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Cipla Limited, Cipla USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1875719.) - filed by Bristol-Myers Squibb Company. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Entered: 02/11/2016)

Entry #1 • 2016-02-11
1
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Cipla Limited, Cipla USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1875719.) - filed by Bristol-Myers Squibb Company. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Entered: 02/11/2016)

Entry #1 • 2016-02-11
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Cipla Limited, Cipla USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1875719.) - filed by Bristol-Myers Squibb Company. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(nmb) (Entered: 02/11/2016)

Entry #1 • 2016-02-11
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmb) (Entered: 02/11/2016)

Entry #2 • 2016-02-11
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 1/7/2016. Date of Expiration of Patent: 12/21/2018.Thirty Month Stay Deadline: 7/7/2018. (nmb) (Entered: 02/11/2016)

Entry #3 • 2016-02-11
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc